Is Maximus Legit?
Maximus holds an open FDA warning letter over compounded-GLP-1 marketing claims (it sells weight-loss medication through the same account as its TRT program) — that's the reason its transparency score is capped. Its BBB record is unremarkable: two duplicate-looking filings at the same address (B-/B+), no major complaint pattern. Innerbody's independent #1 ranking for 2026 predates and doesn't account for the FDA letter.
Legal entity: Maximus Health, Inc.. Scored 7.5/10, ranked #15 of 20 clinics we track.
FDA warning letter on file
Maximus Health, Inc. dba Maximus — MARCS-CMS 730095, issued 2026-06-08 (Center for Drug Evaluation and Research (CDER)).
FDA states it reviewed maximustribe.com (FDA Establishment Identifier 3032037948) in May 2026 and found the site offering compounded semaglutide and tirzepatide products with claims — "Clinically studied ingredients," "Clinically studied to help patients…," "Proven to lose weight effectively" — that FDA alleges falsely imply the compounded product is FDA-approved-equivalent when it is not. FDA states this makes the products misbranded under FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]. Same template as the Hims/Strut/SkinnyRx letters on our sister site — concerns Maximus' compounded-GLP-1 marketing (it also sells weight-loss medication through the same account), not its TRT program specifically.
This is an allegation in FDA's opening enforcement communication — not an adjudicated finding of wrongdoing. See the full picture across every clinic we track →
Third-party records
What we found outside Maximus's own site — BBB, its named pharmacy partner (or lack of one), and whether it publishes a real HIPAA notice.
Better Business Bureau
B+ rating · not BBB accredited · 7 complaints filed (checked 2026-08-30)
Two BBB filings exist at the identical address with the same start date — "Maximus Tribe" (B-, 17 complaints/3yr) and "Maximus Health, Inc" (B+, 7 complaints/3yr, matches the FDA letter's entity name and lists maximustribe.com directly). Read as duplicate filings for the same company rather than two businesses; combined complaint exposure across both listings is 24/3yr.
Pharmacy partner
Inconclusive — every fetch attempt returned truncated content (page too large to load fully). Cannot confirm whether a pharmacy is named or not.
HIPAA disclosure
Inconclusive — same fetch-size limitation as the pharmacy check above.
This page states a legal/regulatory record, not a purchase recommendation. Read the full Maximus review → for pricing, treatment options, and our scored verdict against every clinic we track.
A low score or an open finding is a measurement against our published rubric, not an accusation — see our editorial policy →.